Sichenzia Ross Ference LLP Represents Aegis Capital in $16.0 Million Initial Public Offering of Inspira Technologies OXY B.H.N. Ltd
Press Release – New York, NY – July 19, 2021 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in the initial public offering of 2,909,091 units of Inspira Technologies OXY B.H.N. Ltd (the Company), an Israeli specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology. The offering was priced at $5.51 per unit, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share. The ordinary shares and warrants are trading on NASDAQ under the symbols “IINN” and “IINNW”, respectively.
In addition, the Company granted Aegis Capital Corp. a 45-day option to purchase up to 436,363 additional ordinary shares and/or 436,363 warrants to purchase 436,363 ordinary shares at the public offering price to cover over-allotments. The underwriter partially exercised its over-allotment option with respect to 436,363 warrants to purchase ordinary shares.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Avital Perlman and Jeffrey Cahlon.
- Sichenzia Ross Ference LLP Represents Good Gaming, Inc. in $3.1 Million Private Placement Offering - November 18, 2021
- The Growing Risk of Website Accessibility Litigation and How to Protect Your Business Against It - November 18, 2021
- Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED B.V. in $11.5 Million U.S. Initial Public Offering - November 10, 2021